These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4309 related articles for article (PubMed ID: 22087457)

  • 21. Pancreatic involvement in Erdheim-Chester disease: a case report and review of the literature.
    Dai JW; He TH; Duan MH; Li Y; Cao XX
    BMC Gastroenterol; 2022 Jun; 22(1):302. PubMed ID: 35729495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
    Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease.
    Ambrosini V; Savelli F; Merli E; Zompatori M; Nanni C; Allegri V; Fanti S
    Clin Nucl Med; 2012 Feb; 37(2):196-7. PubMed ID: 22228352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PET.
    Kim M; Rowe SP; Mehta TI
    Am J Case Rep; 2024 Mar; 25():e941169. PubMed ID: 38553814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erdheim-Chester disease: symmetric uptake in the (99m)Tc-MDP bone scan.
    Zanglis A; Valsamaki P; Fountos G
    Hell J Nucl Med; 2008; 11(3):164-7. PubMed ID: 19081860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of (99m)Tc-MDP bone scan in the diagnosis of Erdheim-Chester disease.
    Mukherjee A; Damle N; Bal C; Arora A; Singhal A; Tripathi M; Peepre K
    Indian J Nucl Med; 2014 Jul; 29(3):165-7. PubMed ID: 25210284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
    Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma.
    Skoura E; Oikonomopoulos G; Vasileiou S; Kyprianou D; Koumakis G; Datseris IE
    Hell J Nucl Med; 2014; 17(1):58-61. PubMed ID: 24563879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates.
    Ding H; Li Y; Ruan C; Gao Y; Wang H; Zhang X; Liao Z
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():150055. PubMed ID: 26527559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pediatric hypophosphatemic rickets on MRI,
    Xu C; Ma C; Bai Y
    Hell J Nucl Med; 2017; 20(1):93-96. PubMed ID: 28315917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease.
    Pereira Neto CC; Roman C; Johnson M; Jagasia M; Martin WH; Delbeke D
    Mol Imaging Biol; 2004; 6(1):63-7. PubMed ID: 15018830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
    Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease].
    Adam Z; Balsíková K; Pour L; Krejcí M; Svacina P; Dufek M; Kren L; Hermanová M; Moulis M; Vanícek J; Neubauer J; Mechl M; Prásek J; Stanícek J; Koukalová R; Hájek R; Mayer J
    Vnitr Lek; 2009 Dec; 55(12):1173-88. PubMed ID: 20070034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease.
    Arnaud L; Malek Z; Archambaud F; Kas A; Toledano D; Drier A; Zeitoun D; Cluzel P; Grenier PA; Chiras J; Piette JC; Amoura Z; Haroche J
    Arthritis Rheum; 2009 Oct; 60(10):3128-38. PubMed ID: 19790052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease].
    Girszyn N; Arnaud L; Villain D; Kahn JE; Piette AM; Bletry O
    Rev Med Interne; 2007 Nov; 28(11):770-4. PubMed ID: 17629593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
    Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
    Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA; Bal C; Bandopadhyaya GP; Kumar L; Kumar P; Malhotra A; Lata S
    Jpn J Radiol; 2013 Apr; 31(4):262-9. PubMed ID: 23377765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Resolution of Lytic Lesions in Erdheim-Chester Disease on 18F-FDG PET/CT.
    Yadav D; Seth R; Shamim SA; Kumar R
    Clin Nucl Med; 2020 Dec; 45(12):e514-e515. PubMed ID: 32604106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 216.